Circulation, Vol 53, 315-321, Copyright © 1976 by American Heart Association
PR Foster, RM King, AB Nicoll and DP Zipes
Three groups of dogs were given ouabain (mean 60 mug/kg) until an
accelerated ventricular escape (AVE) and repetitive ventricular response
(RVR) followed cessation of pacing. In a group of six control dogs, the AVE
and RVR were found to occur at stable escape intervals for periods of at
least three hours. A second group of dogs received various antiarrhythmic
agents in an attempt to suppress the AVE and RVR. Quinidine,
diphenylhydration, lidocaine, procainamide, and propranolol, were
successful in only 0 to 33% of trials. Potassium canrenoate, 12 mg/kg was
unsuccessful in three dogs. Verapamil, by bolus, suppressed RVR in 41% and
AVE in 21% of trials. KCl, infused until AVE and RVR were suppressed, was
successful when the mean serum potassium rose from 3.8 mEq/L to 7.2 mEq/L.
Aprindine, 2.86 mg/kg, suppressed AVE and RVR in 14 of 14 dogs. In the
third group of dogs, verapamil was infused continuously and suppressed RVR
and AVE at a mean cumulative dose of 2.93 mg/kg. Calcium chloride reversed
aprindine and verapamil-induced suppression of RVR and AVE. This study
demonstrates that RVR and AVE resist suppression by available
antiarrhythmic agents in clinically-used doses. Only aprindine was 100%
successful at doses used in man. The ionic pathogenesis of RVR and AVE is
unknown, but some data suggest the slow current may play an important role.
ARTICLES
Suppression of ouabain-induced ventricular rhythms with aprindine HCl. A comparison with other antiarrhythmic agents
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1976 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |